FDA Approves First mRNA Flu Vaccine The US Food and Drug Administration (FDA) has approved the first flu vaccine using messenger RNA (mRNA) technology, marking a significant breakthrough in vaccine development.
Moderna Therapeutics' new vaccine offers improved protection against seasonal influenza. What's in the mRNA Flu Vaccine?
At its core, the mRNA flu vaccine works by introducing a piece of genetic material into the body that instructs cells to produce a harmless fragment of the virus.